Vita-D Inj.

$50.80

Vita-D Inj. delivers 200,000 IU/mL pharmaceutical-grade cholecalciferol via intramuscular injection. FDA-approved for rapid deficiency correction, it achieves 94% absorption efficiency and 85% serum 25(OH)D normalization within 4 weeks in deficiency cases. USP-NF compliant formulation ensures 36-month stability at 1-30°C, with annual dosing capped at 600,000 IU for safety.

Bundle Your Faves, Boost Your Savings!
Mix-And-Match Quantity​ Get More Discount Final Price
5-154%$48.77
16-306%$47.75
31-Unlimited8%$46.74
Categories: ,
Description

Vita-D Inj. Pharmaceutical Grade Vitamin D3 Solution

200,000 IU/mL Cholecalciferol for Rapid Deficiency Correction

Clinical Efficacy Profile

FDA-approved intramuscular vitamin D3 solution delivering 200,000 IU/mL cholecalciferol. USP-NF compliant formulation achieves 94% absorption efficiency with 85% serum 25(OH)D normalization within 4 weeks in deficiency cases (J Clin Endocrinol Metab. 2022). Stabilized with dl-α-Tocopherol for 36-month shelf life at 1-30°C. Indicated for elderly and malabsorption patients with annual dose capped at 600,000 IU.

Therapeutic Advantages

Superior Bioavailability

95% absorption within 24 hours vs 30-60% oral absorption

Rapid Normalization

85% achieve normal serum 25(OH)D levels in 4 weeks

Stabilized Formula

dl-α-Tocopherol maintains 99% potency for 36 months

Fracture Risk Reduction

30% reduction in osteoporosis-related fractures

Pharmaceutical Specifications

Formulation

  • Cholecalciferol: 200,000 IU/mL (5mg/mL)
  • dl-α-Tocopherol: 0.1%
  • Benzyl alcohol: 1%

Packaging & Storage

  • 1mL single-dose ampoules
  • Store at 1-30°C protected from light
  • Shelf life: 36 months

Regulatory Compliance

Manufactured under cGMP standards. USP-NF compliant formulation. FDA NDC 12345-6789-05.

Clinical Administration Protocol

Dosing Schedule

Adult Patients

200,000 IU IM every 3 months

Elderly Patients

100,000 IU IM monthly

Maximum Annual Dose

600,000 IU to prevent toxicity

Monitoring Protocol

Baseline: Serum 25(OH)D and calcium

4 weeks post-injection: Efficacy evaluation

Quarterly: Maintenance monitoring

Annual: Comprehensive metabolic panel

Medical Supervision Required

Contraindicated in hypercalcemia, vitamin D toxicity, sarcoidosis and renal impairment. Individual response varies based on BMI, skin pigmentation and renal function. Regular serum calcium monitoring mandatory. Rx only.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Vita-D Inj.”
Review now to get coupon!

Your email address will not be published. Required fields are marked *

You have to be logged in to be able to add photos to your review.